IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'

Travere Therapeutics Travere Therapeutics TVTX $ 66.18 $1.72 2.67% 37% IBD Stock Analysis Stock trying to clear shelf buy point at 66.24 above recent base TVTX Relative Strength line at highs Poised for profitability IBD Composite Rating 80/99 Industry Group Ranking 8/197 Emerging Pattern Consolidation Consolidation A sideways pattern that doesn’t fit traditional base definitions. Sometimes will have a handle.…